Brief: Rohto Pharmaceutical Co Ltd Acquisition Of Shares In And Tender Offer For EU Yan Sang International Ltd, A Singapore Health And Wellness Manufacturing And Sales Company

Rohto Pharmaceutical

04/04/2024 07:08

Rohto Pharmaceutical Co Ltd  4527.T :
    * ROHTO PHARMACEUTICAL CO LTD: ACQUISITION OF SHARES IN AND
TENDER
OFFER FOR EU YAN SANG INTERNATIONAL LTD, A SINGAPORE HEALTH AND
WELLNESS MANUFACTURING AND SALES COMPANY
    * ROHTO PHARMACEUTICAL CO LTD: TO JOINTLY ACQUIRE
APPROXIMATELY
86% OF ISSUED ORDINARY SHARES OF EU YAN SANG INTERNATIONAL LTD
WITH MITSUI & CO
    * ROHTO PHARMACEUTICAL CO LTD: UPON FULFILLMENT OF CONDITION
TO
SHARE ACQUISITION, WE WILL CONDUCT A MANDATORY GENERAL OFFER FOR
REMAINING 14% OF ISSUED ORDINARY SHARES OF EYS
    * ROHTO PHARMACEUTICAL CO LTD: VALUE ATTRIBUTED TO 100% OF
SHARES
OF EYS IS APPROXIMATELY 800 MILLION SINGAPORE DOLLARS
    * ROHTO PHARMACEUTICAL CO LTD: AFTER THE TENDER OFFER ,
MITSUI &
CO. IS EXPECTED TO HOLD ABOUT 30% EFFECTIVE INTEREST IN EYS,
WITH ROHTO HOLDING ABOUT 60%, AND FOUNDING FAMILY REINVESTING IN
SPC AS PART OF MANAGEMENT RETENTION ARRANGEMENTS AND HOLDING
ABOUT 10%

Source text for Eikon:  ID:nTSpd8a36f 
Further company coverage:  4527.T